Margarita
Sanchez del Río González
Colaboradora Médica
![Foto de Margarita](/img/nophoto.png)
![Foto de Eli Lilly and Company](/img/noimage_org.png)
Eli Lilly and Company
Indianapolis, EE. UU.Eli Lilly and Company-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
Benefit–Risk Assessment of Galcanezumab Versus Placebo for the Treatment of Episodic and Chronic Migraine Using the Metrics of Number Needed to Treat and Number Needed to Harm
Advances in Therapy, Vol. 38, Núm. 8, pp. 4442-4460